
juli is a digital healthcare startup focused on improving the lives of people with chronic conditions. Their AI-powered platform integrates data from smartphones, wearables, environmental factors, and self-reported information to help patients identify triggers and make small behavior changes. juli aims to improve patient self-management and provide care managers with insights into patient status. The company has demonstrated efficacy in two independent clinical trials for asthma and depression, with retention and engagement tenfold industry standards. Their platform includes features like a dashboard for data overview, medication reminders, a chat for daily check-ins, and 'Daily Dares' gamified therapeutic exercises.

juli is a digital healthcare startup focused on improving the lives of people with chronic conditions. Their AI-powered platform integrates data from smartphones, wearables, environmental factors, and self-reported information to help patients identify triggers and make small behavior changes. juli aims to improve patient self-management and provide care managers with insights into patient status. The company has demonstrated efficacy in two independent clinical trials for asthma and depression, with retention and engagement tenfold industry standards. Their platform includes features like a dashboard for data overview, medication reminders, a chat for daily check-ins, and 'Daily Dares' gamified therapeutic exercises.
What: AI-powered mobile app for self-management of chronic conditions
Founded: 2020
Headquarters: Boston / East Boston, Massachusetts
Employees: 53
Notable evidence: Published randomized controlled trial results for asthma and depression
Chronic condition self-management (asthma, migraine, depression, bipolar disorder, hypertension, chronic pain)
2020
Digital health / Healthcare
3800000.00
Seed round announced March 3, 2022
Most recent funding event reported as a grant on October 16, 2024
“Seed and strategic investors include Speedinvest, Norrsken, SoftBank's Vision Fund Emerge, Dieter von Holtzbrinck Ventures; later funding includes Manulife Financial and Tenity”